Skip to main content

Table 4 Most frequent serious side effects noted during the study (n)

From: Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: A sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients

Reported Side Effects

Irbesartan

Irbesartan/HCTZ

1 Cardiogenic shock

1

2

2 Cerebral infarction

1

1

3 Gastrointestinal hemorrhage

1

1

4 Metastatic bronchial carcinoma

1

1

5 Myocardial infarction

2

1

6 Rash

1

1

7 Tachyarrhythmia

1

1

8 Vertigo

1

1

  1. out of a total of 14,200 patients
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840